project id: TCGA-LUSC; case submitter id: TCGA-90-A59Q; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22420; days to death: 322; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1951; age at diagnosis: 22420; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 269.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 4.383561643835616; pack years smoked: 80.0; is ffpe: false; composition: Not Reported; days to collection: 52; days to sample procurement: 0; initial weight: 190.0; portion submitter id: TCGA-90-A59Q-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 5.0; percent necrosis: 10.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 65.0;